Guo G,Gui Y,Gao S,Tang A,Hu X,Huang Y,Jia W,Li Z,He M,Sun L,Song P,Sun X,Zhao X,Yang S,Liang C,Wan S,Zhou F,Chen C,Zhu J,Li X,Jian M,Zhou L,Ye R,Huang P,Chen J,Jiang T,Liu X,Wang Y,Zou J,Jiang Z,Wu R,Wu S,Fan F,Zhang Z,Liu L,Yang R,Liu X,Wu H,Yin W,Zhao X,Liu Y,Peng H,Jiang B,Feng Q,Li C,Xie J,Lu J,Kristiansen K,Li Y,Zhang X,Li S,Wang J,Yang H,Cai Z and Wang J
Shenzhen Key Laboratory of Transomics Biotechnologies, BGI-Shenzhen, Shenzhen, China.
We sequenced whole exomes of ten clear cell renal cell carcinomas (ccRCCs) and performed a screen of ∼1,100 genes in 88 additional ccRCCs, from which we discovered 12 previously unidentified genes mutated at elevated frequencies in ccRCC. Notably, we detected frequent mutations in the ubiquitin-mediated proteolysis pathway (UMPP), and alterations in the UMPP were significantly associated with overexpression of HIF1α and HIF2α in the tumors (P = 0.01 and 0.04, respectively). Our findings highlight the potential contribution of UMPP to ccRCC tumorigenesis through the activation of the hypoxia regulatory network.